HQL
Otherabrdn Life Sciences Investors
$18.22+0.32 (+1.79%)PRE
Live · NYSE · May 9, Close
AI Insight
What's Moving HQL Today?
No stock-specific AI insight has been generated for HQL yet. Check back soon — insights are generated from recent news analysis.
Fundamentals
Market Cap$554M
P/E Ratio—
EPS—
Dividend Yield—
Dividend / Share—
ROE—
Profit Margin—
Debt / Equity—
Trading
Volume132K
Avg Volume (10D)—
Shares Outstanding30.4M
HQL News
3 articles- Aberdeen Investments U.S. Closed-End Funds Announce Distribution Payment DetailsYahoo Finance·Mar 31, 2026
- Certain Aberdeen Investments U.S. Closed-End Funds Declare Distribution Dates and AmountsYahoo Finance·Feb 10, 2026
- ABERDEEN INVESTMENTS U.S. CLOSED-END FUNDS ANNOUNCE RESULTS OF ANNUAL MEETING OF SHAREHOLDERSYahoo Finance·May 28, 2025
All 3 articles loaded
Price Data
Open$17.89
Previous Close$17.90
Day High$18.00
Day Low$17.75
52 Week High—
52 Week Low—
Fundamentals
Market Cap$554M
P/E Ratio—
EPS—
Dividend Yield—
Dividend / Share—
ROE—
Profit Margin—
Debt / Equity—
Trading
Volume132K
Avg Volume (10D)—
Shares Outstanding30.4M
About abrdn Life Sciences Investors
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mainly in securities of life sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser to have the potential for above-average growth.
Listed May 1, 1992
Company Details
Security TypeETF
ExchangeNYSE
Currency—
Round Lot—
SIC—
CIK—
Composite FIGI—
Share Class FIGI—